Teladoc Stock Gains As Amazon Partnership Fuels Push for Consumer-Centric Healthcare
Partnership with Amazon: Teladoc Health has partnered with Amazon to enhance access to its chronic condition management programs, allowing eligible Amazon customers to enroll in services for diabetes, hypertension, pre-diabetes, and weight management.
Stock Performance and Predictions: Teladoc's shares have risen by 7.94% in premarket trading, with analysts using technical analysis to predict future stock performance based on moving averages and trends, indicating a generally bullish outlook if the stock remains above its 200-day moving average of $10.07.
Trade with 70% Backtested Accuracy
Analyst Views on BUYO
About the author
Magnite's Growth Prospects Strengthen As CTV, Regulation Shift In Its Favor
Analyst Coverage Initiation: Barton Crockett from Rosenblatt has initiated coverage on Magnite, Inc. with a Buy rating and a price target of $18, highlighting the company's growth despite challenges posed by Google and its potential for further expansion in the Connected TV and programmatic advertising sectors.
Revenue Forecasts and Market Position: The analyst projects revenues of $747 million for 2025 and $819 million for 2026, slightly below consensus estimates, while suggesting that macroeconomic conditions may improve post-2026, potentially benefiting Magnite's performance.
Teladoc Stock Gains As Amazon Partnership Fuels Push for Consumer-Centric Healthcare
Partnership with Amazon: Teladoc Health has partnered with Amazon to enhance access to its chronic condition management programs, allowing eligible Amazon customers to enroll in services for diabetes, hypertension, pre-diabetes, and weight management.
Stock Performance and Predictions: Teladoc's shares have risen by 7.94% in premarket trading, with analysts using technical analysis to predict future stock performance based on moving averages and trends, indicating a generally bullish outlook if the stock remains above its 200-day moving average of $10.07.
How bond ETFs fared as investors parsed new inflation, jobless-claims data
Bond-Fund Performance: This week's ETF Wrap focuses on the performance of bond funds as investors reacted to new inflation and jobless claims data released on Thursday.
Contact Information: Readers are encouraged to provide feedback and tips via email or follow the authors on social media platforms.
Magnite's Growth Prospects Strengthen As CTV, Regulation Shift In Its Favor
Analyst Coverage Initiation: Barton Crockett from Rosenblatt has initiated coverage on Magnite, Inc. with a Buy rating and a price target of $18, highlighting the company's growth despite challenges posed by Google and its potential for further expansion in the Connected TV and programmatic advertising sectors.
Revenue Forecasts and Market Position: The analyst projects revenues of $747 million for 2025 and $819 million for 2026, slightly below consensus estimates, while suggesting that macroeconomic conditions may improve post-2026, potentially benefiting Magnite's performance.
Teladoc Stock Gains As Amazon Partnership Fuels Push for Consumer-Centric Healthcare
Partnership with Amazon: Teladoc Health has partnered with Amazon to enhance access to its chronic condition management programs, allowing eligible Amazon customers to enroll in services for diabetes, hypertension, pre-diabetes, and weight management.
Stock Performance and Predictions: Teladoc's shares have risen by 7.94% in premarket trading, with analysts using technical analysis to predict future stock performance based on moving averages and trends, indicating a generally bullish outlook if the stock remains above its 200-day moving average of $10.07.
How bond ETFs fared as investors parsed new inflation, jobless-claims data
Bond-Fund Performance: This week's ETF Wrap focuses on the performance of bond funds as investors reacted to new inflation and jobless claims data released on Thursday.
Contact Information: Readers are encouraged to provide feedback and tips via email or follow the authors on social media platforms.
